257 related articles for article (PubMed ID: 30206495)
21. A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.
Muijs CT; Beukema JC; Pruim J; Mul VE; Groen H; Plukker JT; Langendijk JA
Radiother Oncol; 2010 Nov; 97(2):165-71. PubMed ID: 20541273
[TBL] [Abstract][Full Text] [Related]
22. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
[TBL] [Abstract][Full Text] [Related]
23. FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer.
Bar-Ad V; Shi W; Tuluc M; Ohri N; Cognetti D; Curry J; Intenso C
J Nucl Med Radiat Ther; 2012 Feb; 3(1):. PubMed ID: 24179702
[TBL] [Abstract][Full Text] [Related]
24. The role of positron emission tomography/computed tomography in radiation therapy planning for patients with lung cancer.
Mac Manus MP; Hicks RJ
Semin Nucl Med; 2012 Sep; 42(5):308-19. PubMed ID: 22840596
[TBL] [Abstract][Full Text] [Related]
25. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?
Hanna GG; Carson KJ; Lynch T; McAleese J; Cosgrove VP; Eakin RL; Stewart DP; Zatari A; O'Sullivan JM; Hounsell AR
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1040-51. PubMed ID: 20350798
[TBL] [Abstract][Full Text] [Related]
26. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
[TBL] [Abstract][Full Text] [Related]
27. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?
Devic S; Tomic N; Faria S; Menard S; Lisbona R; Lehnert S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1555-62. PubMed ID: 20646840
[TBL] [Abstract][Full Text] [Related]
28. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
29. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
[TBL] [Abstract][Full Text] [Related]
30. Evaluating diffusion-weighted magnetic resonance imaging for target volume delineation in head and neck radiotherapy.
Cardoso M; Min M; Jameson M; Tang S; Rumley C; Fowler A; Estall V; Pogson E; Holloway L; Forstner D
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):399-407. PubMed ID: 30816646
[TBL] [Abstract][Full Text] [Related]
31. Impact of FDG-PET on lung cancer delineation for radiotherapy.
Morarji K; Fowler A; Vinod SK; Ho Shon I; Laurence JM
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):195-203. PubMed ID: 22498194
[TBL] [Abstract][Full Text] [Related]
32. [Interest of FDG-PET for lung cancer radiotherapy].
Thureau S; Mezzani-Saillard S; Modzelewski R; Edet-Sanson A; Dubray B; Vera P
Cancer Radiother; 2011 Oct; 15(6-7):504-8. PubMed ID: 21880535
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer.
Lavrenkov K; Partridge M; Cook G; Brada M
Radiother Oncol; 2005 Oct; 77(1):1-4. PubMed ID: 16225943
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
35. F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.
Fleckenstein J; Hellwig D; Kremp S; Grgic A; Gröschel A; Kirsch CM; Nestle U; Rübe C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e283-9. PubMed ID: 21470782
[TBL] [Abstract][Full Text] [Related]
36. Defining a radiotherapy target with positron emission tomography.
Black QC; Grills IS; Kestin LL; Wong CY; Wong JW; Martinez AA; Yan D
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1272-82. PubMed ID: 15519800
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
Vinod SK; Kumar S; Holloway LC; Shafiq J
J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
[TBL] [Abstract][Full Text] [Related]
38. Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.
van Velden FH; Kramer GM; Frings V; Nissen IA; Mulder ER; de Langen AJ; Hoekstra OS; Smit EF; Boellaard R
Mol Imaging Biol; 2016 Oct; 18(5):788-95. PubMed ID: 26920355
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy volume delineation using dynamic [
Silvoniemi A; Din MU; Suilamo S; Shepherd T; Minn H
Int J Comput Assist Radiol Surg; 2016 Nov; 11(11):2059-2069. PubMed ID: 26811083
[TBL] [Abstract][Full Text] [Related]
40. Variation in background intensity affects PET-based gross tumor volume delineation in non-small-cell lung cancer: the need for individualized information.
Chen GH; Yao ZF; Fan XW; Zhang YJ; Gao HQ; Qian W; Wu KL; Jiang GL
Radiother Oncol; 2013 Oct; 109(1):71-6. PubMed ID: 24060171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
